Not sure this helps us much. The problem is augmentation. A vaccine could take a healthy young person who would have had an asymptomatic infection, and change that into severe disease. Infecting them with an attenuated strain doesn't give enough certainty about the risk of augmentation with the real thing.
It is also a large effort to produce a medical grade attenuated strain that you could infect people with in a trial.